Lv3
220 积分 2025-06-04 加入
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
8天前
已关闭
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
10天前
已完结
-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
1个月前
已完结
Small cell lung carcinoma: Eight types of extension and spread on computed tomography
1个月前
已完结
Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer
3个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
3个月前
已完结
Small-cell lung cancer
4个月前
已完结
Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer
5个月前
已完结
Gut microbiota predictive of the efficacy of consolidation immunotherapy and chemoradiotherapy toxicity in lung cancer
5个月前
已完结
Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy
5个月前
已完结
皖公网安备34019202002308
